CD24 and neoplasm: Significant therapeutic survival benefit was observed in vaccine groups either with CD24-Fc or with IgG-Fc when compared with tumor only control groups in both models, but the anti-tumor effect was more profound in the model of delayed CD24-Fc treatment (Figure 6).